What is the Return on Assets (ROA) of Zymeworks this year?
The Return on Assets (ROA) of Zymeworks is -0.2 undefined this year.
Zymeworks ROA 2024
Zymeworks ROA
-0.2
Ticker
ZYME
ISIN
CA98985W1023
WKN
A2DP0F
In 2024, Zymeworks's return on assets (ROA) was -0.2, a -206.62% increase from the 0.19 ROA in the previous year.
Zymeworks Aktienanalyse
What does Zymeworks do?
Zymeworks Inc is a biotechnology company that was founded in 2003. The company is headquartered in Vancouver, Canada. The founders of the company were a group of researchers specializing in the development of antibodies. Their goal was to develop a platform technology that allows for the design and production of highly specific and effective antibodies. Zymeworks Inc's platform technology is based on the use of protein engineering technologies such as Immunoglobulin G competences (IgG). This allows for the targeted production of antibodies that bind to specific target molecules. The business model of Zymeworks Inc is based on licensing its platform technology to other companies. The licensees use Zymeworks' platform to develop antibodies or other proteins for their own pharmaceutical research. Zymeworks Inc has various business areas that specialize in the different applications of its platform technology. This includes cancer immunotherapy, the treatment of autoimmune diseases, and the development of biological therapeutics. The company also offers products that can be used directly by patients, such as a test kit for determining the risk of breast cancer. Over the years, Zymeworks Inc has expanded its business areas and formed partnerships with major pharmaceutical companies. In summary, Zymeworks Inc is a leading biotechnology company specializing in the development of antibodies and other proteins. It has a unique platform technology that allows its customers to develop targeted antibodies and therapeutic proteins. Its products are used in various areas, including cancer immunotherapy, the treatment of autoimmune diseases, and biological therapeutics. Zymeworks ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Zymeworks's Return on Assets (ROA)
Zymeworks's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Zymeworks's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Zymeworks's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Zymeworks’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Zymeworks stock
What was the ROA of Zymeworks compared to the previous year?
The ROA of Zymeworks has increased by -206.62% compared to the previous year.
What consequences do high ROA have for investors of Zymeworks?
A high ROA is advantageous for investors of Zymeworks, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Zymeworks?
A low ROA can be unfavorable for investors of Zymeworks as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Zymeworks affect the company?
An increase in ROA of Zymeworks can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Zymeworks impact the company?
A reduction in the ROA of Zymeworks can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Zymeworks?
Some factors that can influence the ROA of Zymeworks include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Zymeworks important for investors?
The ROA of Zymeworks is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Zymeworks take to improve ROA?
To improve ROA, Zymeworks can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Zymeworks pay?
Over the past 12 months, Zymeworks paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Zymeworks is expected to pay a dividend of 0 USD.
What is the dividend yield of Zymeworks?
The current dividend yield of Zymeworks is .
When does Zymeworks pay dividends?
Zymeworks pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Zymeworks?
Zymeworks paid dividends every year for the past 0 years.
What is the dividend of Zymeworks?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Zymeworks located?
Zymeworks is assigned to the 'Health' sector.
Wann musste ich die Aktien von Zymeworks kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Zymeworks from 10/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.
When did Zymeworks pay the last dividend?
The last dividend was paid out on 10/4/2024.
What was the dividend of Zymeworks in the year 2023?
In the year 2023, Zymeworks distributed 0 USD as dividends.
In which currency does Zymeworks pay out the dividend?
The dividends of Zymeworks are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Zymeworks
Our stock analysis for Zymeworks Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zymeworks Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
